Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
14
2
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
36%
5 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Haemodynamic Effects and Complications of Continuous Versus Single-shot Spinal Anaesthesia for HIP Fracture Surgery
Role: collaborator
Erector Spinae Plane (ESP) Block vs Intravenous Lignocaine Infusion in (VATS)
Role: lead
EPidural's Impact on Contractions and Fetal REsponse
Role: lead
The Influence of Oxytocin on Intrapartum Fetal Well-being and Delivery Outcomes in Patients Receiving Epidural Analgesia
Role: lead
The HF-POL Study - Multicenter Study of Polish Patients With HF and LVEF >40%
Role: collaborator
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
Role: collaborator
Annuloplasty for Not-Severe TR in Patients Undergoing MV Repair Versus Mitral Repair Only (NOSTRUM)
Role: collaborator
Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic
Role: collaborator
Registry on Left Main Coronary Artery Bifurcation Percutaneous Intervention
Role: collaborator
Stand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation.
Role: lead
BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations
Role: lead
First-in-man Sirolimus-eluting Prolim® Stent Registry
Role: lead
DES Versus BiOSS LIM - POLBOS II Study
Role: lead
POLish Bifurcation Optimal Stenting Study
Role: lead
All 14 trials loaded